Charles River Laboratories International Inc (NYSE:CRL) Share Price

Company Profile

Business description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Contact
251 Ballardvale Street
WilmingtonMA01887
USA
T: +1 781 222-6000
E: [email protected]
https://www.criver.com
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
20,100

Recommended

Streaming giant’s stellar results had areas of softness; currency tailwinds drive guidance raise.

Matthew Dolgin, CFA | 23 July 2025

A recent $1 billion investment in CBA by Texas based fund manager expresses concern for the outlook of the USD.

John Abernethy | 23 July 2025

The offer price is well above our fair value.

Shaun Ler | 22 July 2025

Index	Last price	Change	% Change
All Ordinaries	9,001.40	59.90	0.67%
CAC 40	7,850.43	106.02	1.37%
DAX 40	24,240.82	198.92	0.83%
Dow JONES (US)	45,010.29	507.85	1.14%
FTSE 100	9,061.49	37.68	0.42%
HKSE	25,538.07	408.04	1.62%
NASDAQ	21,020.02	127.33	0.61%
Nikkei 225	41,171.32	1,396.40	3.51%
NZX 50 Index	12,807.99	13.93	0.11%
S&P 500	6,358.91	49.29	0.78%
S&P/ASX 200	8,737.20	60.00	0.69%
SSE Composite Index	3,582.30	0.44	0.01%